openPR Logo
Press release

Adrenocortical Carcinoma Treatment Market to Witness Comprehensive Growth by 2025

08-07-2017 07:38 AM CET | Health & Medicine

Press release from: Persistence Market Research

Adrenocortical Carcinoma Treatment Market to Witness

Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer is what happens when another form of cancer spreads to the adrenal glands. Adrenocortical carcinoma can occur at any age, but there is a bimodal distribution with a first peak at childhood between 1–6 years old and the second peak in the fourth to the fifth decade of life. During the past decade, collaborative efforts have been made to improve the ACC treatment.

To access full report @ http://www.persistencemarketresearch.com/market-research/adrenocortical-carcinoma-treatment-market.asp

Adrenocortical Carcinoma Treatment Market: Drivers and Restraints

Some of the key factors that are driving the adrenocortical carcinoma treatment market are increasing the prevalence of cancer, rising government involvement, increasing funding from various government and non-government organizations. Also, ethical acceptance of adrenocortical carcinoma treatment and high unmet needs in some regions are driving the adrenocortical carcinoma treatment market. However, less awareness and high cost involved in treatment are restraining the global adrenocortical carcinoma treatment market. Also, the introduction of generic drugs in some countries is restraining the growth of adrenocortical carcinoma treatment market. Also, despite the high cost involved in R&D, pharmaceutical companies are showing increased interest in this field. This is expected to offer good potential for adrenocortical carcinoma treatment market.

Adrenocortical Carcinoma Treatment Market: Overview

Although it mainly occurs in adults, children are also affected by adrenocortical carcinoma. Based on data from the International Pediatric Adrenocortical Tumor Registry, the median age at which children develop adrenal carcinomas is 3.2 years. 60% are younger than four years, and 14% are older than 13 years. Historically, only about 30% of these malignancies are confined to the adrenal gland at the time of diagnosis. However, recently, more adrenocortical carcinoma cases have been diagnosed in early states, most likely due to the widespread use of high-quality imaging techniques. The female-to-male ratio for adrenocortical carcinoma is approximately 2.5-3:1. The accumulation of data, especially in international registries, revealed the incidence of adrenal tumors to be higher in female individuals than had previously been thought, particularly in those aged 0-3 years and those over 13 years. Nonfunctional adrenocortical carcinomas are distributed equally between the sexes.

Adrenocortical Carcinoma Treatment Market: Region-wise Outlook

Regionally, the market can be segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America and Europe dominate the global adrenocortical carcinoma treatment market. The U.S. represents the largest market for adrenocortical cancer followed by which is Canada. In Europe, France, Germany and the U.K. holds the major share of adrenocortical cancer treatment. However, Asia is expected to show high growth rates in the next five years in global adrenocortical carcinoma treatment market. Japan, China, and India are expected to be the fastest-growing markets in Asia.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/16918

Adrenocortical Carcinoma Treatment Market: Key Players

Some of the players of adrenocortical carcinoma treatment market include ArQule, Inc., EnGeneIC Ltd., Exelixis, Inc., Merck KGA, Millendo Therapeutics, and Orphagen Pharmaceuticals, Inc. Some of the latest trends that have been observed in this market include companies involved in partnerships and R&D for more efficient technologies.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adrenocortical Carcinoma Treatment Market to Witness Comprehensive Growth by 2025 here

News-ID: 657266 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Adrenocortical

Adrenocortical Hormones API Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Adrenocortical Hormones API market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Adrenocortical Hormones APImarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Adrenocortical Hormones APImarket, market definition, overview, industry opportunities
Adrenocortical Hormones API Industry Outlook and Forecast 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Adrenocortical Hormones API industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Adrenocortical Hormones API and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). The recent report added by GLOBAL INFO RESEARCH gives a detailed account of the drivers and restraints in the global Adrenocortical Hormones API market. The research report,
Adrenocortical Carcinoma Therapeutics - Pipeline Analysis 2018, Clinical Trials …
Adrenocortical carcinoma, also known as adrenal cortex carcinoma, is a rare form of cancer that occurs at the cortex layer of the adrenal gland. There are two adrenal glands present in the human body: one at the top of each kidney. Download the sample report @ https://www.pharmaproff.com/request-sample/1109 Each adrenal gland is comprised of two distinct structures: the outer part of the adrenal glands (adrenal cortex) and the inner region (adrenal medulla). Some
Adrenocortical Carcinoma Epidemiology: Genetic History of Carney Complex a Proba …
Characterized by cancerous growth in adrenal glands, adrenocortical carcinoma is identified as a rare disease, affecting children and adult alike. However, lack of symptoms at early stages hampers prognosis, thus encouraging significant advancement in adrenocortical carcinoma therapeutics. A new business intelligence report titled, 'Adrenocortical Carcinoma-Market Insights, Epidemiology and Market Forecast-2027' included in the vast online data archive of Market Research Hub (MRH) identifies current market developments and their reciprocal implications
Adrenocortical Carcinoma Treatment Market: Segment Snapshot and Table of Content …
Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer
Adrenocortical Carcinoma Treatment Market Opportunities and Forecasts, 2017 – …
Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer